CytRx Corp said 60 pct owned CytRx Biopool Ltd subsidiary acquired Biopool AB Umea , Sweden , undisclosed term .
It said former shareholder Biopool AB remaining 40 pct CytRx Biopool Ltd. Biopool AB develops cardiovascular fibrinolytic product diagnostic application .
The company said CytRx Biopool studying possible combination CytRx Corp 's RheothRx drug reduce platelet aggregation viscosity blood Biopool AB 's drug t-PA dissolving blood clot .
Reuter & # 3 ; 